WallStSmart
ARQT

Arcutis Biotherapeutics Inc

NASDAQ: ARQT · HEALTHCARE · BIOTECHNOLOGY

$22.37
-3.95% today

Updated 2026-04-29

Market cap
$2.91B
P/E ratio
P/S ratio
7.75x
EPS (TTM)
$-0.13
Dividend yield
52W range
$12 – $32
Volume
1.3M

Arcutis Biotherapeutics Inc (ARQT) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item201720182019202020212022202320242025
Revenue$0.00$0.00$0.00$0.00$0.00$3.69M$59.61M$196.54M$376.07M
Revenue growth (YoY)+1517.1%+229.7%+91.3%
Cost of revenue$195000.00$455000.00$763000.00$754000.00$4.99M$19.13M$36.70M
Gross profit$-195000.00$-455000.00$-763000.00$2.93M$54.62M$177.41M$339.38M
Gross margin79.5%91.6%90.3%90.2%
R&D$3.41M$17.94M$36.52M$115.31M$145.56M$182.44M$110.58M$76.42M$77.05M
SG&A$695000.00$1.79M$6.61M$21.34M$60.97M$122.12M$173.49M$222.49M$274.55M
Operating income$-4.11M$-19.73M$-43.13M$-136.65M$-206.53M$-301.63M$-241.10M$-128.40M$-12.23M
Operating margin-8183.0%-404.5%-65.3%-3.3%
EBITDA$-4.11M$-19.25M$-41.80M$-135.22M$-206.07M$-294.55M$-227.43M$-109.63M$2.48M
EBITDA margin-7991.1%-381.6%-55.8%0.7%
EBIT$-4.11M$-19.73M$-42.00M$-135.68M$-206.53M$-295.81M$-229.31M$-112.22M$-2.89M
Interest expense$0.00$0.00$0.00$0.00$454000.00$15.65M$29.71M$27.17M$12.08M
Income tax
Effective tax rate0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income$-4.98M$-19.25M$-42.00M$-135.68M$-205.90M$-311.46M$-262.14M$-140.04M$-16.14M
Net income growth (YoY)-286.8%-118.1%-223.1%-51.8%-51.3%+15.8%+46.6%+88.5%
Profit margin-8449.8%-439.8%-71.3%-4.3%